- $1.09bn
- $1.26bn
- $863.50m
- 26
- 64
- 76
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 902 | 1,435 | 1,775 | 1,004 | 863 |
Cost of Revenue | |||||
Gross Profit | 329 | 541 | 582 | 288 | 318 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,176 | 1,378 | 1,756 | 1,230 | 1,021 |
Operating Profit | -274 | 57.7 | 18.8 | -226 | -157 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -305 | 48.7 | -14 | -392 | -184 |
Provision for Income Taxes | |||||
Net Income After Taxes | -312 | 31.1 | -29.5 | -328 | -189 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -315 | 30.6 | -30.1 | -328 | -189 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -315 | 30.6 | -30.1 | -328 | -189 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.425 | 0.049 | -0.078 | -0.473 | -0.251 |